Marco Mazzone
VP, China & Int’l Strategic Partner + Global Medical Information
Chiesi
Building the future-fit Medical Affairs function.
Two days with senior Medical Affairs leaders from Chiesi, Angelini, Ferring, CSL Vifor and Boehringer Ingelheim — turning scientific engagement, real-world evidence and patient partnership into measurable impact.
Faculty from
What does a truly future-fit Medical Affairs model look like — and why do most fail?
Measuring real impact on HCP behaviour and clinical practice.
Registry design and data-source standards that satisfy both payers and regulators.
Do patient support programmes improve outcomes — or just adherence metrics?
Preparing to support novel endpoints regulators are only beginning to understand.
Medical Affairs 2030: leading AI disruption and empowered patients — or reacting to it?
VP, China & Int’l Strategic Partner + Global Medical Information
Chiesi
Global Medical Affairs Director, Brain Health
Angelini Pharma
Head of Medical Affairs UK/IRE/Malta, WECAN region
Ferring Pharmaceuticals
Head of Medical Affairs — Intercontinental & Partner Business
CSL Vifor Pharma
Global Lead, Medical Affairs Evolution & Metrics
Boehringer Ingelheim
Case Study 01 · Medical Information
How GMI evolves from a reactive service to a strategic driver — generating insight, leveraging AI, and enabling faster Medical Affairs decisions.
Marco Mazzone · Chiesi
Case Study 02 · Patient Partnership
Turning patient centricity from a guiding principle into a measurable practice across evidence, design and outcomes.
Elena Alvarez-Baron · Angelini Pharma
Case Study 03 · Collaboration
What genuine collaboration requires, why Medical Affairs is best placed to lead it, and where the real challenges lie.
Mayura Deshpande · Ferring
Case Study 04 · Strategy
Building capability across partner and distributor networks, and supporting launches of specialty and rare-disease products.
Sangeetha Anand · CSL Vifor
Case Study 05 · Metrics
A framework moving from activity metrics to changes in behaviour and, ultimately, patient outcomes.
Reinhard Berkels · Boehringer Ingelheim
The full two-day programme releases soon.
See the agenda →Compare approaches with Directors and VPs from Europe’s leading pharma companies.
Real frameworks and results — not theory — you can apply on Monday.
Board, C-level, VPs and Heads of Department across the Medical Affairs function.
A small, high-trust format designed for genuine discussion, not broadcast.
Reach a concentrated room of senior Medical Affairs decision-makers.
Lead Partner
4C Pharma Solutions
Join senior Medical Affairs leaders in Berlin this September.
Limited seats · Early-rate registration closing soon